To download a PDF version of this PDF, click here!<\/a><\/p>\n In 2020, the Food and Drug Administration licensed an additional meningococcal serogroups A, C, W, and Y (MenACWY) \u2013 MenQuadfi MenQuadfi is now available for providers enrolled in the Vaccines for Children (VFC) program.<\/strong> This advisory includes an overview MenQuadfi is licensed for use in individuals 2 years and older in the United States.<\/strong><\/p>\n VFC supplies of MenQuadfi may be given to VFC-eligible children aged 2 years through 18 years.<\/p>\n MenQuadfi is for intramuscular use only.<\/p>\n MenQuadfi is approved for routine vaccination of children and teens, age 11 through 18 years: a single dose at age 11 or 12 years with a booster dose at age 16 years.<\/p>\n MenQuadfi may also be used for children at increased risk who are age 2 years and older (the primary dosing schedule and booster dose interval varies by age and indication):<\/p>\n These recommendations are summarized in Table 3 of the recommendations published by ACIP in MMWR in 2020: www.cdc.gov\/mmwr\/volumes\/69\/rr\/pdfs\/rr6909a1-H.pdf<\/a>.<\/p>\n The Advisory Committee on Immunization Practices (ACIP) recommends that whenever feasible, the same manufacturer\u2019s brand should be used to complete the series. However, if the previous brand is unavailable or unknown, any brand may be used to complete the series. Do not defer immunization solely to wait for a specific meningococcal vaccine brand to be available. From age 2 years and up the MenACWY vaccines are interchangeable.<\/p>\n MenQuadfi is available for ordering through the PhilaVax IIS as of today, June 8, 2021. Please contact Christine Wilson (Christine.Wilson@phila.gov<\/a>) or Charma Miller (Charma.Miller@phila.gov<\/a>) to add MenQuadfi to your next order. Please note, your practice must choose a single product to order for each antigen. We recommend that sites that are part of a system, or are affiliated, use the same vaccine presentations across sites to ensure continuity of care and help prevent administration errors.<\/p>\n MenQuadfi (MenACYW-TT), a New Meningococcal Vaccine, is Now Available for VFC To download a PDF version of this PDF, click here! In 2020, the Food and Drug Administration licensed an additional meningococcal serogroups A, C, W, and Y (MenACWY) \u2013 MenQuadfi (MenACYW-TT), from Sanofi Pasteur…<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[139],"tags":[],"class_list":["post-10987","post","type-post","status-publish","format-standard","hentry","category-vfc"],"_links":{"self":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/10987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/comments?post=10987"}],"version-history":[{"count":0,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/posts\/10987\/revisions"}],"wp:attachment":[{"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/media?parent=10987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/categories?post=10987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vaccines.phila.gov\/index.php\/wp-json\/wp\/v2\/tags?post=10987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n(MenACYW-TT), from Sanofi Pasteur Inc.<\/p>\n
\nof important information about MenQuadfi.<\/p>\nRecommendations For Use<\/h2>\n
Eligible Groups for Receipt of VFC Supplies of MenQuadfi<\/h3>\n
Licensed Dosing Schedule<\/h3>\n
\n
Storage<\/h4>\n
\n
How MenQuadfi is supplied<\/h4>\n
\n
Ordering and Billing<\/h2>\n
\n
Resources<\/h2>\n
\n